Kisspeptin 10 mg

Kisspeptin 10 mg contains kisspeptin-10, a research peptide that stimulates the hypothalamic-pituitary-gonadal axis through GPR54 receptor activation. In research settings it is used to study reproductive hormone regulation. In non-medical bodybuilding contexts, it is sometimes referenced as a potential alternative to HCG, though such use falls outside approved indications and the FDA has concluded that there is insufficient evidence to support its effectiveness for male hypogonadism.

Clinical research has primarily used intravenous bolus or infusion administration. In non-medical community contexts, protocols commonly reference 100–200 mcg per administration once daily, with some users reporting 500 mcg per day. Common reference ranges for this compound in non-medical contexts are not well characterized.

Kisspeptin is sometimes referenced as a component of post-cycle therapy rather than requiring PCT itself, based on its upstream mechanism at the hypothalamic level. Unlike HCG, which can cause desensitization with prolonged use, kisspeptin’s mechanism is non-suppressive. However, the FDA has concluded that there is insufficient evidence to support its effectiveness for this purpose.

Kisspeptin-10 binds to the GPR54 receptor on GnRH neurons in the hypothalamus, stimulating GnRH release, which in turn drives pituitary LH and FSH secretion. It is one of the most potent activators of the HPG axis known to date. This upstream mechanism distinguishes it from direct gonadotropin analogs like HCG.

Clinical studies have shown that intravenous kisspeptin-10 triggers immediate LH pulse induction, with effects observed within minutes of administration. In healthy male volunteers, kisspeptin-10 administration resulted in rapid dose-dependent LH peaks. Any cumulative effects on reproductive hormone levels would develop over the course of administration.

There is no single compound that is universally best for HPG axis stimulation. HCG 5000 IU provides direct LH receptor stimulation and is FDA-approved for specific indications. Gonadorelin is a synthetic GnRH analog that acts on the same pathway. Kisspeptin-10 operates upstream at the hypothalamic level but has not been established as effective for male hypogonadism.

HCG 5000 IU acts directly on Leydig cells as an LH mimetic, bypassing the hypothalamic-pituitary axis entirely. Kisspeptin-10 acts upstream at the hypothalamus to stimulate GnRH release. This means kisspeptin requires a functional HPG axis, whereas HCG does not. In men with suppressed HPG axes, kisspeptin-10 failed to elicit LH responses in one small study.

Gonadorelin is a synthetic GnRH analog that binds directly to GnRH receptors on pituitary gonadotrophs. Kisspeptin-10 acts upstream by stimulating endogenous GnRH release from hypothalamic neurons. The two compounds therefore act at different levels of the HPG axis, though both ultimately increase LH and FSH secretion.

Clinical research has used doses ranging from 0.01 to 4 μg/kg intravenously, which for a typical 80 kg individual translates to roughly 0.8–320 mcg. Community protocols commonly reference 100–200 mcg per administration. The 10 mg vial contains 10,000 mcg total, providing 50–100 doses at these levels.

Kisspeptin 10 mg is labeled at 10 mg of kisspeptin-10 per vial. It is supplied as a lyophilized powder in a 2 mL vial, requiring reconstitution before use.

No published laboratory report is currently available for this specific product. Product potency and purity verification would apply to tested samples only and should not be interpreted as a measurement of every vial or production batch.

Lyophilized kisspeptin-10 is typically reconstituted with a suitable solvent such as Bacteriostatic Water or sterile water. The volume of solvent added determines the concentration of the resulting solution. Proper sterile technique should be used during reconstitution.